EDF’s Neltner raises concern about FDA’s cell-based consultation process

摘要

While regulatory approval remains a top priority for cell-based meat companies, a consumer advocate is raising concerns that FDA may be turning to an oversight system that will not be robust and transparent enough for these novel products.